Clinical Pearl

Intestinal decontamination with rifaximin may prevent the formation of a first episode of spontaneous bacterial peritonitis (SBP) for cirrhotic patients with large ascites.  Because this new finding comes from a retrospective analysis, prospective randomized trials are required.  Nevertheless, for patients with multiple drug allergies (penicillins, quinolones, sulfa) who may benefit from rifaximin for other reasons (ie. hepatic encephalpathy), there is reason to be excited about its use as SBP prophylaxis.

For more:

This entry was posted in Clinical Pearl. Bookmark the permalink.

Leave a Reply

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s